Elevated Levels of Mannose-Binding Lectin (MBL) in patients with Type 2 Diabetes and its Potential Association with Nephropathy and Retinopathy

The hepatic protein Mannose-binding lectin (MBL) serves a pivotal role in the acute-phase immune response, potentially influencing the pathogenesis of type 2 diabetes (T2DM) and its associated complications, such as nephropathy and retinopathy. Recent evidence suggests that elevated plasma MBL levels may serve as a predictive marker for albuminuria in T2DM patients. Moreover, it is postulated that MBL ligands are present within the kidneys of diabetic individuals, thereby facilitating the deposition of MBL within the renal parenchyma or other target organs, thereby exacerbating pathological processes. This study aimed to assess serum MBL levels in T2DM patients and explore potential associations between MBL levels and the onset of diabetic complications. A cross-sectional investigation was conducted, encompassing 92 participants, comprising 71 individuals diagnosed with T2DM and 21 age- and sex-matched healthy counterparts. Among the T2DM cohort, patients were stratified into nephropathic and non-nephropathic subgroups based on the presence of nephropathy, as well as into subgroups with or without retinopathy based on retinopathy status. Serum MBL levels were quantified utilizing Enzyme-Linked Immunosorbent Assay (ELISA). The mean MBL levels were found to be significantly elevated in diabetic patients compared to healthy controls (1736 vs. 730.99 ng/mL, p-value = 0.011). Furthermore, MBL levels exhibited a statistically significant increase in individuals with microalbuminuria compared to normoalbuminuric T2DM patients (p-value = 0.019). Notably, a significant association was observed between heightened MBL levels in diabetic patients and the occurrence of retinopathy. The findings of this study support the hypothesis implicating MBL in the pathogenesis of T2DM and the initiation and progression of its associated complications, including nephropathy and retinopathy. Nevertheless, further investigation is warranted to delineate the precise underlying mechanisms governing the relationship between MBL and T2DM pathophysiology.

Authors

Institutions

Publication Details

Journal
Research Journal of Pharmacy and Technology
Published
2025-04-12
DOI
https://doi.org/10.52711/0974-360x.2025.00226
Primary Topic
Complement system in diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Elevated Levels of Mannose-Binding Lectin (MBL) in patients with Type 2 Diabetes and its Potential Association with Nephropathy and Retinopathy

Shereen M. Aleidi, Yasser Bustanji, Amani A. Harb, Bashar A. Alkhalidi et al.
Research Journal of Pharmacy and Technology
Complement system in diseases
article

Elevated Levels of Mannose-Binding Lectin (MBL) in patients with Type 2 Diabetes and its Potential Association with Nephropathy and Retinopathy

Shereen M. Aleidi, Yasser Bustanji, Amani A. Harb, Bashar A. Alkhalidi, Islam Hamad, Omar Sallam, Mohammad Mohammad, Hanan Mohammad, Eman Abu-Gharbieh, Haneen El-Huneidi, Y. Abu-Rish Eman
article en

Abstract

The hepatic protein Mannose-binding lectin (MBL) serves a pivotal role in the acute-phase immune response, potentially influencing the pathogenesis of type 2 diabetes (T2DM) and its associated complications, such as nephropathy and retinopathy. Recent evidence suggests that elevated plasma MBL levels may serve as a predictive marker for albuminuria in T2DM patients. Moreover, it is postulated that MBL ligands are present within the kidneys of diabetic individuals, thereby facilitating the deposition of MBL within the renal parenchyma or other target organs, thereby exacerbating pathological processes. This study aimed to assess serum MBL levels in T2DM patients and explore potential associations between MBL levels and the onset of diabetic complications. A cross-sectional investigation was conducted, encompassing 92 participants, comprising 71 individuals diagnosed with T2DM and 21 age- and sex-matched healthy counterparts. Among the T2DM cohort, patients were stratified into nephropathic and non-nephropathic subgroups based on the presence of nephropathy, as well as into subgroups with or without retinopathy based on retinopathy status. Serum MBL levels were quantified utilizing Enzyme-Linked Immunosorbent Assay (ELISA). The mean MBL levels were found to be significantly elevated in diabetic patients compared to healthy controls (1736 vs. 730.99 ng/mL, p-value = 0.011). Furthermore, MBL levels exhibited a statistically significant increase in individuals with microalbuminuria compared to normoalbuminuric T2DM patients (p-value = 0.019). Notably, a significant association was observed between heightened MBL levels in diabetic patients and the occurrence of retinopathy. The findings of this study support the hypothesis implicating MBL in the pathogenesis of T2DM and the initiation and progression of its associated complications, including nephropathy and retinopathy. Nevertheless, further investigation is warranted to delineate the precise underlying mechanisms governing the relationship between MBL and T2DM pathophysiology.

Research Journal of Pharmacy and Technology
Al-Ahliyya Amman University (JO), University of Jordan (JO), Jordan University of Science and Technology (JO), University of Sharjah (AE)
Openalex Percentile: Top 89%
Complement system in diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.